Home Tags NASDAQ:SRNE

Tag: NASDAQ:SRNE

What Analysts Claims About Fossil Group, Inc. (FOSL) and Sorrento Therapeutics,...

Fossil Group, Inc. (NASDAQ:FOSL) attracted a lower number of shares in volume with 1.53 million contracts traded on 13-Dec-18. However, its trading capacity stayed...

Let’s Talk About What’s Happening to Sorrento Therapeutics, Inc. (SRNE) and...

Heading into the close, a volume-active day saw Sorrento Therapeutics, Inc. (NASDAQ:SRNE) moving down $-0.33 from the opening price. The volume for the company...

There Is Reason to Like Carnival Corporation (CCL) and Sorrento Therapeutics,...

For Carnival Corporation (NYSE:CCL) Thursday was another day of strong-handed buying, with the high volume day punctuated by a rise from previous close. Trading...

27.7% Of Sorrento Therapeutics, Inc. (SRNE) Is Owned By Hedge Funds

Sorrento Therapeutics, Inc. (NASDAQ:SRNE) recovered 51.16% of its value since hitting low of $2.15. The recent move of -8.71% drop pushed the stock to...

Analyst Views On Top Movers In Recent Trade: Sorrento Therapeutics, Inc....

Sorrento Therapeutics, Inc. (NASDAQ:SRNE) notched a -2.04% intraday decline moving at $3.36. When the opening bell rang, the price was $3.4. The number of...

What The Investing World Hopes From Sorrento Therapeutics, Inc. (SRNE), CubeSmart...

Friday seemed like a lighter volume day for Sorrento Therapeutics, Inc. (NASDAQ:SRNE), but it might not be harder to recover from. Trade volumes fell...

Here’s What To Do With Pioneer Natural Resources Company (PXD), Sorrento...

Optimism reigned on a brightened-volume day for Pioneer Natural Resources Company (NYSE:PXD) which lost $-3.25 between open and close. The number of shares traders...

An Interesting Valuation Case? – Gilead Sciences, Inc. (GILD), Sorrento Therapeutics,...

Investors making a wish list of stocks to watch should take a look at Gilead Sciences, Inc. (NASDAQ:GILD). The stock is offering a price-to-sales...

Can A Similar Series of Events Expected At Sorrento Therapeutics, Inc....

Sorrento Therapeutics, Inc. (NASDAQ:SRNE) enjoyed a fine run from the open in trading on 11/07/2018 with increased volume coming into the shares and a...

Vulcan Materials Company (VMC) Valuation Up While Sorrento Therapeutics, Inc. (SRNE)...

Here's what's interesting to note about Vulcan Materials Company (NYSE:VMC) right now: Its price-to-sales ratio of 4.3, is expensive relative to the General Building...